Stericycle (SRCL) Misses Q2 EPS by 27c, Revenues Beat; Offers FY19 EPS Guidance Below Consensus, Affirms FY19 Revenue Outlook
Tweet Send to a Friend
Stericycle (NASDAQ: SRCL) reported Q2 EPS of $0.56, $0.27 worse than the analyst estimate of $0.83. Revenue for the quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
